AOD-9604 is a modified peptide fragment derived from the C-terminal region of human growth hormone (hGH), specifically designed to stimulate fat breakdown without the muscle-building effects associated with full hGH therapy. It functions by targeting and promoting lipolysis (fat breakdown) and inhibiting lipogenesis (formation of new fat), making it popular in weight management treatments.
AOD-9604 has been studied for its potential to increase metabolism and reduce body fat in a controlled manner, and it works by acting on the pituitary gland. Unlike hGH, it does not influence insulin levels, making it a potentially safer option for some individuals seeking weight loss solutions without impacting blood sugar control Metabolic studies of a synthetic lipolytic domain (AOD9604)]
(https://pubmed.ncbi.nlm.nih.gov/11146367/) 2. en.wikipedia.org – AOD9604 3. focalpointvitality.com – AOD 9604 Peptide Therapy 4. tspace.library.utoronto.ca – The skeletal effects of a growth hormone-derived peptide 5. eliteplasticsurgeryaz.com – Peptide/Hormone Therapy 6. jofem.org – Safety and Tolerability of the Hexadecapeptide AOD9604